Home » Psychology news » Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests

Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests

June 1, 2013 by

Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>